FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:1470 April 2, 2009 Number 14

PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Burn, J.

Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome . In Table 2 (pages 2572–2573), the third variable should be "Age at recruitment — yr," and the age ranges should read as follows: Aspirin plus Resistant Starch, 25–70; Aspirin plus Placebo, 25–75; Resistant Starch plus Placebo, 25–75; Placebo plus Placebo, 25–78; Aspirin Only, 37–67; Placebo Only, 33–57; Resistant Starch Only, 28–78; and Placebo Only, 36–75. In the first paragraph under Outcomes (page 2573), the data given in the fourth sentence should read, "66 of 350 (18.9%) had one or more neoplastic lesions while receiving aspirin, as compared with 65 of 343 in the placebo group (19.0%)." The article has been corrected at NEJM.org.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.